These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37478391)

  • 1. Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer.
    Swinton M; Mariam NBG; Tan JL; Murphy K; Elumalai T; Soni M; Ferrera A; Richardson C; Walshaw R; Mistry H; Ramani V; Song Y; Birtle A; Henry A; Chan J; Hoskin P; Choudhury A
    J Clin Oncol; 2023 Sep; 41(27):4406-4415. PubMed ID: 37478391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
    Moschini M; Mattei A; Cornelius J; Shariat SF; Dell'Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
    Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
    Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
    Arcangeli G; Strigari L; Arcangeli S
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):387-96. PubMed ID: 25934521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
    von Deimling M; Furrer M; Mertens LS; Mari A; van Ginkel N; Bacchiani M; Maas M; Pichler R; Li R; Moschini M; Bianchi A; Vetterlein MW; Lonati C; Crocetto F; Taylor J; Tully KH; Afferi L; Soria F; Del Giudice F; Longoni M; Laukhtina E; Antonelli A; Rink M; Fisch M; Lotan Y; Spiess PE; Black PC; Kiss B; Pradere B; Shariat SF;
    BJU Int; 2024 Mar; 133(3):341-350. PubMed ID: 37904652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
    Afferi L; Zamboni S; Karnes RJ; Roghmann F; Sargos P; Montorsi F; Briganti A; Gallina A; Mattei A; Schulz GB; Hendricksen K; Voskuilen CS; Rink M; Poyet C; De Cobelli O; di Trapani E; Simeone C; Soligo M; Simone G; Tuderti G; Alvarez-Maestro M; Martínez-Piñeiro L; Aziz A; Shariat SF; Abufaraj M; Xylinas E; Moschini M;
    World J Urol; 2021 Feb; 39(2):443-451. PubMed ID: 32356226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
    Huddart RA; Birtle A; Maynard L; Beresford M; Blazeby J; Donovan J; Kelly JD; Kirkbank T; McLaren DB; Mead G; Moynihan C; Persad R; Scrase C; Lewis R; Hall E
    BJU Int; 2017 Nov; 120(5):639-650. PubMed ID: 28453896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.
    Voskuilen CS; Seiler R; Rink M; Poyet C; Noon AP; Roghmann F; Necchi A; Aziz A; Lavollé A; Young MJ; Marks P; Saba K; van Rhijn BWG; Fransen van de Putte EE; Ablat J; Black PC; Sosnowski R; Dobruch J; Kumar P; Jallad S; Catto JWF; Xylinas E; Hendricksen K;
    Eur Urol Focus; 2020 Nov; 6(6):1226-1232. PubMed ID: 30559065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model.
    Al-Alao O; Mueller-Leonhard C; Kim SP; Amin A; Tucci C; Kott O; Mega A; Golijanin D; Gershman B
    Urol Oncol; 2020 Mar; 38(3):76.e19-76.e28. PubMed ID: 31590968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.
    Kumar A; Cherry DR; Courtney PT; Nalawade V; Kotha N; Riviere PJ; Efstathiou J; McKay RR; Karim Kader A; Rose BS; Stewart TF
    Eur Urol Open Sci; 2021 Aug; 30():1-10. PubMed ID: 34337540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
    Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
    Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.
    García-Perdomo HA; Montes-Cardona CE; Guacheta M; Castillo DF; Reis LO
    World J Urol; 2018 Dec; 36(12):1997-2008. PubMed ID: 29943218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
    Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
    Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy.
    Zaffuto E; Bandini M; Moschini M; Leyh-Bannurah SR; Gazdovich S; Dell'Oglio P; Gallina A; Shariat SF; Briganti A; Montorsi F; Saad F; Karakiewicz PI
    Eur Urol Oncol; 2018 Jun; 1(2):169-175. PubMed ID: 31100242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies.
    Shen PL; Lin ME; Hong YK; He XJ
    World J Surg Oncol; 2018 Oct; 16(1):197. PubMed ID: 30285788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
    Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer.
    Afferi L; Lonati C; Montorsi F; Briganti A; Necchi A; Mari A; Minervini A; Tellini R; Campi R; Schulz GB; Black PC; di Trapani E; de Cobelli O; Karnes RJ; Ahmed M; Mir MC; Algarra MA; Rink M; Zamboni S; Mondini F; Simeone C; Antonelli A; Tafuri A; Krajewski W; Małkiewicz B; Xylinas E; Soria F; Sanchez Salas R; Arora A; Cathelineau X; Hendricksen K; Ammiwala M; Borghesi M; Chierigo F; Teoh JY; Mattei A; Albisinni S; Roghmann F; Roumiguié M; Bajeot AS; Maier E; Aziz A; Hurle R; Contieri R; Pradere B; Carando R; Poyet C; Alvarez-Maestro M; D'Andrea D; Shariat SF; Moschini M;
    Eur Urol Oncol; 2022 Dec; 5(6):722-725. PubMed ID: 35715319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis.
    Su X; Dong C; Liao W; Liu W
    World J Surg Oncol; 2023 Aug; 21(1):271. PubMed ID: 37641150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.